Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis

Farid Abushamat, Christoph F. Dietrich, Dirk Andre Clevert, Fabio Piscaglia, David T. Fetzer, Maria Franca Meloni, Masoud Shiehmorteza, Yuko Kono

Research output: Contribution to journalArticlepeer-review


Hemoperitoneum in cirrhosis is a life-threatening condition that requires emergent evaluation. Contrast-enhanced ultrasound (CEUS) permits multiple dynamic characterizations of abdominal structures through all vascular phases, and contrast extravasation or the presence of microbubbles in the ascites could be a sensitive tool. We reviewed 13 patients with cirrhosis that underwent CEUS due to high suspicion for intra-abdominal bleeding. In 10 cases, CEUS demonstrated extravasation of contrast, including 2 instances where CEUS detected active bleeding despite negative computed tomography. These data support further study of CEUS in direct comparison to other imaging modalities in this clinical context.

Original languageEnglish (US)
JournalJournal of Ultrasound in Medicine
StateAccepted/In press - 2022


  • bleeding
  • CEUS
  • cirrhosis
  • hemoperitoneum

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis'. Together they form a unique fingerprint.

Cite this